Works matching IS 13520504 AND DT 2016 AND VI 23 AND IP 2
Results: 10
Hepatitis E: an emerging global disease - from discovery towards control and cure.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 68, doi. 10.1111/jvh.12445
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 65, doi. 10.1111/jvh.12453
- Publication type:
- Article
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 139, doi. 10.1111/jvh.12469
- By:
- Publication type:
- Article
Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 116, doi. 10.1111/jvh.12472
- By:
- Publication type:
- Article
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 123, doi. 10.1111/jvh.12484
- By:
- Publication type:
- Article
Understanding decisions made about hepatitis C treatment by couples who inject drugs.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 89, doi. 10.1111/jvh.12451
- By:
- Publication type:
- Article
Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 80, doi. 10.1111/jvh.12464
- By:
- Publication type:
- Article
Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjects.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 96, doi. 10.1111/jvh.12470
- By:
- Publication type:
- Article
HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 130, doi. 10.1111/jvh.12450
- By:
- Publication type:
- Article
Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 2, p. 105, doi. 10.1111/jvh.12471
- By:
- Publication type:
- Article